“…Both the physician assessed symptom scores and the patients' scores from the Nottingham health profile showed those with a complete response to radiotherapy had little change in their QoL. Zietman et al published comparable findings for 71 patients who were alive and disease-free a median of 6.3 years (range 1.6-14.9) following transurethral resection, chemotherapy and radiotherapy for MIBC [13]. They used a QoL questionnaire validated for prostate cancer, adapted for the study, and included domains for sexual and physical function, global health functional status, and measures of body awareness.…”